In this issue:
Bone pain at diagnosis and survival in mHSPC
Lifetime health and economic outcomes of biparametric MRI screening
Cardiovascular events and androgen receptor signaling inhibitors
Immune checkpoint blockade in mCRPC with CDK12 alterations
Salvage SBRT for recurrent prostate cancer after brachytherapy
Cytoreductive radical prostatectomy for oligometastatic disease on PSMA PET/CT
Outcomes of biopsy grade group 1 prostate cancer diagnosis
Targeted microwave ablation for prostate cancer
PSMA PET/CT and prostate cancer salvage radiotherapy planning
Prostate size and cancer-specific outcomes in localised prostate cancer
Please login below to download this issue (PDF)